Latest Pharma News update... Aug 26
If approved, Zeposia would be the first oral sphingosine-1-phosphate (S1P) receptor modulator for the treatment of ulcerative colitis.... Dec 28
Zydus Cadila has received tentative approval to market 11 mg Tofacitinib Extended-Release Tablets... Oct 19
-Advertisements-